BRL

Mylan's Alphapharm wins patent litigation on generic Razadyne tablets - 09/01 - 10:57 AM ET

Barr wins FDA approval for generic Razadyne tablets - 08/29 - 12:14 PM ET

Barr Pharmaceuticals Inc announces receipt of FDA approval for generic Razadyne tablets - 08/29 - 04:18 AM ET

Barr Receives Approval for Generic Version of Razadyne(R) Tablets - 08/28 - 12:18 PM ET

Barr Announces Favorable Ruling in Razadyne(R) Patent Challenge - 08/28 - 08:48 AM ET

Barr confirms patent challenge of schizophrenia drug - 08/26 - 11:22 AM ET

/C O R R E C T I O N -- Barr Pharmaceuticals, Inc. (NYSE: BRL)/ - 08/21 - 12:26 PM ET

Barr Laboratories (NYSE: BRL) NewsBite - BRL Hits 52-Week High - 08/18 - 03:10 AM ET

First At-Home Screening Test for Amniotic Fluid Leakage During Pregnancy Now Available - 08/12 - 03:13 PM ET

Barr Pharmaceuticals Reaffirms - 08/07 - 07:51 AM ET

BRL: Q2 Earnings Call @ 08:30 ET Today [delayed] - 08/07 - 07:31 AM ET

Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share - 08/07 - 07:25 AM ET

Barr confirms patent challenge of Xyzal 5mg tablets - 08/01 - 09:35 AM ET

Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets - 07/31 - 11:57 AM ET

Barr confirms patent challenge of Sensipar tablets - 07/30 - 11:42 AM ET

Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg - 07/29 - 09:10 AM ET

Barr confirms patent challenge of Fentora tablets - 07/25 - 12:02 PM ET

Barr Confirms Patent Challenge of Fentora(R) Tablets - 07/24 - 02:45 PM ET

Barr Pharmaceuticals Breaks Over Range, Hits 2-Year High - 07/23 - 01:16 PM ET

Bedford County in the dark on Barr deal - 07/19 - 07:13 AM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index